These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6968353)

  • 1. Blood lymphocytes in infectious mononucleosis share the following characteristics with activated T cells: natural attachment, stable E rosetting and glucocorticoid sensitivity.
    Galili U; Seeley J; Svedmyr E; Klein E; Klein G; Weiland O
    J Clin Lab Immunol; 1980 May; 3(3):153-8. PubMed ID: 6968353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypical, functional and chromosomal studies of lymphocytes from patients with infectious mononucleosis.
    Jensen JR; Bisballe S; Pedersen EB; Christensen KD; Thestrup-Pedersen K
    Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):9-14. PubMed ID: 6603097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired T lymphocyte colony formation in infectious mononucleosis: evidence for both monocyte and lymphocyte defects.
    Claësson MH; Andersen V
    Clin Exp Immunol; 1979 Dec; 38(3):483-91. PubMed ID: 317032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated T cells in the synovial fluid of arthritic patients. II. In vitro activation of the autologous blood lymphocytes.
    Galili U; Rosenthal L; Klein E
    J Immunol; 1981 Aug; 127(2):430-2. PubMed ID: 6972962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E-rosette test: variations in results using E from different sheep. Effect of FCS and of AET treatment.
    Naess A; Nyland H
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):367-70. PubMed ID: 6608856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased numbers of cells with suppressor T cell phenotype in the peripheral blood of patients with infectious mononucleosis.
    Crawford DH; Brickell P; Tidman N; McConnell I; Hoffbrand AV; Janossy G
    Clin Exp Immunol; 1981 Feb; 43(2):291-7. PubMed ID: 6456093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
    Hudnall SD; Patel J; Schwab H; Martinez J
    Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T lymphocytes in infectious mononucleosis. I. T cell death in vitro.
    Moss DJ; Bishop CJ; Burrows SR; Ryan JM
    Clin Exp Immunol; 1985 Apr; 60(1):61-9. PubMed ID: 3874017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated T lymphocytes in infiltrates and draining lymph nodes of nasopharyngeal carcinoma.
    Galili U; Klein E; Klein G; Singh Bal I
    Int J Cancer; 1980 Jan; 25(1):85-9. PubMed ID: 6249765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T lymphocytes in infectious mononucleosis. II. Response in vitro to interleukin-2 and establishment of T cell lines.
    Bishop CJ; Moss DJ; Ryan JM; Burrows SR
    Clin Exp Immunol; 1985 Apr; 60(1):70-7. PubMed ID: 3874018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens.
    Seeley J; Svedmyr E; Weiland O; Klein G; Moller E; Eriksson E; Andersson K; van der Waal L
    J Immunol; 1981 Jul; 127(1):293-300. PubMed ID: 6263974
    [No Abstract]   [Full Text] [Related]  

  • 12. Auto-rosette formation in the peripheral blood of a patient with infectious mononucleosis.
    Djaldetti M; Zahavi I; Komlos L; Fishman P
    J Submicrosc Cytol; 1983 Apr; 15(2):603-6. PubMed ID: 6854696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T lymphocytes in infectious mononucleosis; effect of IL-2 on the outgrowth of Epstein-Barr virus-infected cells.
    Misko IS; Burrows SR; Schmidt C; Bishop CJ; Ryan JM; Staples JA; Moss DJ
    Immunol Cell Biol; 1989 Feb; 67 ( Pt 1)():49-55. PubMed ID: 2785955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of immunoregulatory T cells in EBV-induced infectious mononucleosis by monoclonal antibodies.
    De Waele M; Thielemans C; Van Camp BK
    N Engl J Med; 1981 Feb; 304(8):460-2. PubMed ID: 6450326
    [No Abstract]   [Full Text] [Related]  

  • 15. [Infectious mononucleosis].
    Yoneyama A
    Rinsho Byori; 2001 Oct; 49(10):996-9. PubMed ID: 11769479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-driven expansion and contraction of CD8+-activated T cells in primary EBV infection.
    Hoshino Y; Morishima T; Kimura H; Nishikawa K; Tsurumi T; Kuzushima K
    J Immunol; 1999 Nov; 163(10):5735-40. PubMed ID: 10553106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4(+) T-cell responses to Epstein-Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV-associated non-Hodgkin lymphoma: Th1 in active disease but Tr1 in remission.
    Marshall NA; Culligan DJ; Johnston PW; Millar C; Barker RN; Vickers MA
    Br J Haematol; 2007 Oct; 139(1):81-9. PubMed ID: 17854310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional studies on tumor-infiltrating lymphocytes in man.
    Klein E; Svedmyr E; Jondal M; Vanky F
    Isr J Med Sci; 1977 Jul; 13(7):747-52. PubMed ID: 303641
    [No Abstract]   [Full Text] [Related]  

  • 19. EBV-related cytotoxicity of Fc receptor negative T lymphocytes separated from the blood of infectious mononucleosis patients.
    Bakacs T; Svedmyr E; Klein E
    Cancer Lett; 1978 Apr; 4(4):185-9. PubMed ID: 206347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and immunological considerations in Epstein-Barr virus-associated diseases.
    Andersson J
    Scand J Infect Dis Suppl; 1996; 100():72-82. PubMed ID: 8860357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.